Instil Bio (TIL) Payables (2020 - 2026)

Instil Bio has reported Payables for 7 years, with the latest figure at $795000.0 in Q2 2026.

• On a quarterly basis, Payables rose 52.01% year-over-year to $795000.0 in Q2 2026; TTM through Jun 2026 was $795000.0, a 52.01% increase from a year earlier, with the FY2025 full-year figure at $779000.0, up 18.21% from the prior year.
• Payables was $795000.0 for Q2 2026 at Instil Bio, roughly flat from $793000.0 in the prior quarter.
• The five-year high for Payables was $7.7 million in Q1 2022, with the low at $286000.0 in Q1 2025.
• Average Payables over 5 years is $2.0 million, with a median of $1.2 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: Payables plunged 82.51% in 2023, then soared 177.27% in 2026.
• Over 5 years, Payables stood at $2.4 million in 2022, then tumbled by 48.62% to $1.2 million in 2023, then tumbled by 45.63% to $659000.0 in 2024, then advanced by 18.21% to $779000.0 in 2025, then climbed by 2.05% to $795000.0 in 2026.
• The last three Payables figures came in at $795000.0 (Q2 2026), $793000.0 (Q1 2026), and $779000.0 (Q4 2025), per Business Quant data.